Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster dose reactogenicity and immunogenicity study of Boostrix Polio in children and adolescents previously vaccinated with dTpa-IPV
2007-003477-94Phase 4Completed
- Sponsor
- GSK
- Start
- Dec 2007
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of Boostrix Polio in diphtheria, Tetanus, pertussis and 1 more, sponsored by GSK. Started Dec 2007; status: completed.
02
Drugs
Boostrix Polio
03
Conditions
diphtheriaTetanuspertussispoliomyelitis
Beyond the preview
Go deeper on 2007-003477-94.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003477-94.